Knowledge

Gamma-Aminobutyric Acid (GABA)

Product Profile

Apply for Sample

Chemical ID: CAS Formula HS Code Database

Gamma-Aminobutyric Acid (GABA)

Property Details Industrial Notes
Product Name & IUPAC Name Gamma-Aminobutyric Acid
IUPAC: 4-aminobutanoic acid
Direct nomenclature use improves traceability in regulatory declarations.
Lot release certificates and compliance documentation require full IUPAC referencing for international shipments.
Chemical Formula C4H9NO2 The molar formula underpins mass balance calculations and trace impurity analysis.
Material balances during synthesis, yield estimates, and batch consistency metrics revolve around precise stoichiometry.
Synonyms & Trade Names GABA, 4-Aminobutyric acid, Piperidinic acid (obsolete), Aminobutyrate Procurement and import/export documentation often reference GABA.
Synonym usage varies by regulatory territory and customer segment.
Trade name assignment may change per region or according to distributor agreements.
HS Code & Customs Classification 2922.49 (Other amino-acids and their esters, salts thereof) HS code application often requires evidence of composition and intended use, especially for nutraceutical, feed, and pharma-bound grades.
Classification interpretations may differ in local customs houses or where GABA’s end-use resides outside standard food/pharma boundaries.
Supporting COA and regulatory declaration documentation from the manufacturer is routinely required for customs clearance.

Technical Properties, Manufacturing Process & Safety Guidelines for Gamma-Aminobutyric Acid (GABA)

Physical & Chemical Properties

Physical State & Appearance

GABA usually appears as a white to off-white crystalline solid or powder in commercial and industrial lots. Its form and color can vary based on synthesis route, purification step, and end-use purity requirements. No characteristic odor can be detected in high-purity grades. For melting point, typical values reported align around 200°C, but this depends on residual moisture, crystallinity, and impurity level. Volatilization or boiling does not occur before decomposition under normal pressure, so boiling point data is generally not relevant for process design. Flash point determination is not typical, since the material is not flammable under standard lab test conditions. Density may vary with compaction and moisture content. Granular formulations may show slightly different flow and bulk properties than fine powders or compacted grades.

Chemical Stability & Reactivity

GABA shows strong chemical stability under ambient, dry, and neutral pH conditions. Hygroscopicity presents in some forms, so exposure to moisture and elevated temperature accelerates clumping and potential degradation, especially for high-purity, low-impurity lots. Chemical degradation or side reactions become notable only under prolonged heat or strong oxidizing environments. For downstream blending, avoid strong acids or bases, which may alter the zwitterionic state and impact solubility or reactivity.

Solubility & Solution Preparation

GABA presents moderate to high water solubility, which shifts with pH and temperature. Solubility in common organic solvents is negligible. During industrial solution preparation, mixing time, solution pH and temperature directly impact dissolution rate and finished concentration. High-purity applications often require aqueous dissolution under nitrogen or argon to minimize trace oxidation. Low-grade or technical grades sometimes generate minor insoluble residues, mainly from processing impurities or undissolved particulates.

Technical Specifications & Quality Parameters

Specification Table by Grade

Specifications follow grade requirement. Pharmaceutical and food additive grades undergo strict limits for key impurity species and residual solvents. Feed or technical quality grades allow wider impurity ranges, and may display variable moisture content, color, and solution clarity.

Parameter Food/Pharma Grade Technical Grade
Purity (as GABA) Highest, grade-defined Typical, application-driven
Moisture Strictly limited Wider range accepted
Heavy Metals Minimum, per regulation Varies with raw material
Color/Form White crystalline Off-white possible

Impurity Profile & Limits

Impurities depend on both synthesis route and upstream raw material quality. Major considerations are heavy metals, amino acid byproducts, and residual solvents. Downstream applications, especially in nutraceutical or pharmaceutical segments, push for minimized non-GABA amino acids and low ash content. Residual moisture and trace element content are monitored batch-wise. Specification targets and acceptance criteria reflect the intended use and applicable regulations.

Test Methods & Standards

Analytical methods include titration, HPLC, GC for volatile residues, and ICP for heavy metals. The chosen method adjusts according to the detection limit required by the grade. Colorimetric analysis applies for quick process control, but final release tests rely on validated, reference-standardized procedures, either international or customer-defined.

Preparation Methods & Manufacturing Process

Raw Materials & Sourcing

Raw material sourcing focuses on precursor purity and supply chain reliability. Industrial manufacture often starts from glutamic acid as the key precursor. Botanically derived or fermentation-sourced inputs are increasingly used where natural label claims or sustainability targets are critical. Chemical precursors must be traceable and supported by a consistent certificate of analysis.

Synthesis Route & Reaction Mechanism

Chief industrial processes involve two routes: biotechnological fermentation using specific microbial strains, or chemical synthesis by decarboxylation of L-glutamic acid through catalytic or thermal means. Route selection determines inherent impurity profiles, with fermentation favoring amino acid selectivity and chemical conversion requiring tighter control of reaction by-products. Each route features unique downstream decolorization and filtration requirements.

Process Control & Purification

Key control points include pH maintenance, temperature regulation, and oxygen exclusion to prevent by-product formation. Multi-stage filtration, activated carbon treatment, or ion-exchange resin purification is selected based on downstream impurity profile. Batch consistency relies on strict process monitoring, real-time analytics, and standardized processing time at each step.

Quality Control & Batch Release

Final quality checks include identity confirmation, assay by titration or HPLC, moisture content, and impurity analysis per grade standard. Additional parameters, such as bulk density and flow properties, are tested for grades intended for direct compaction or blending. Release decisions combine batch analytics, process documentation, and trend data from ongoing quality surveillance.

Chemical Reactions & Modification Potential

Typical Reactions

GABA reacts as a typical zwitterionic amino acid. Industrial modification options target N-alkylation, amidation, or esterification. Such approaches enable formation of derivatives useful in pharmaceutical intermediates or functional food ingredients.

Reaction Conditions

Reaction parameters include controlled temperature, strictly defined pH, selective catalysts or enzymes, and water or polar aprotic solvents. Unwanted side reactions arise if temperature or catalyst choice lacks optimization. Downstream users sometimes perform direct reactions on supplied GABA, with requirements clarified at the technical handover.

Derivatives & Downstream Products

Typical derivatives result from amide or ester linkage modifications. GABA’s backbone supports targeted functionalization for specialty pharma or supplement segments. The choice of pathway considers impact on impurity risk and regulatory acceptance for the target application.

Storage & Shelf Life

Storage Conditions

GABA’s hygroscopic tendency means low humidity and ambient temperature storage, away from direct light sources, prevent caking or degradation. Nitrogen atmosphere may be specified for ultra-high-purity pharmaceutical lots. Product stored under uncontrolled humidity risks agglomeration and color change.

Container Compatibility

High-density polyethylene drums or lined fiber cartons provide sufficient barrier properties for general use. Long-term stability hinges on effective sealing and absence of headspace moisture. Compatibility with stainless steel or glass confirmed for solution storage up to defined shelf intervals.

Shelf Life & Degradation Signs

Shelf life estimation ties directly to grade, packaging integrity, and storage condition. Acceptable shelf periods are finalized per finished-product stability data and regulatory filing. Loss of free-flowing form, color shift, or odor signals degradation, and such product should not be released or reformulated for critical applications.

Safety & Toxicity Profile

GHS Classification

GABA is not classified as hazardous under globally harmonized system parameters for the majority of grades and markets, based on acute oral/dermal toxicity studies. Formulation with other ingredients or for specialized uses triggers re-evaluation by the manufacturer’s safety team.

Hazard & Precautionary Statements

Exposure via ingestion, inhalation of dust, or skin contact requires industrial hygiene standards in handling. Dust management, proper PPE, and ventilation address occupational exposure. Emergency protocols respond to contact or ingestion based on observed acute toxicity data.

Toxicity Data

Published data indicate low acute oral and dermal toxicity. Chronic exposure or high-dose ingestion over long-term period has been evaluated in animal studies for regulatory submission in food and pharma segments. Sensitization or irritation potential remains low, but batch impurity can alter risk for sensitive end uses.

Exposure Limits & Handling

No official occupational exposure limit set for GABA in most production jurisdictions as of technical standard review. Dust exposure limited via engineering controls and operating procedure; respiratory PPE is advised during material transfer and open handling of powders.

Gamma-Aminobutyric Acid (GABA): Supply Capacity, Commercial Terms & 2026 Price Trend Forecast

Supply Capacity & Commercial Terms

Production Capacity & Availability

GABA production output always tracks closely with plant utilization rates, raw material reliability, and process route stability. Our batch and continuous processing lines support both food/healthgrade and technical-grade requirements, and expansion plans adjust in response to regulatory shifts and new application demands. For feed-grade and industrial-grade output, availability hinges on the forward booking of fermentation input stock and effective enzyme utilization rates. Domestic supply in China typically responds fastest to sudden demand surges, whereas requirements in Japan and the EU may face longer constraints due to tighter batch approval intervals and certification prerequisites.

Lead Time & MOQ

Lead time depends on both grade and customer qualification cycle. Typical new orders for basic technical grade ship within two to three weeks, subject to raw material flow and existing order prioritization. Additional time must be allocated for grades requiring multi-point analysis, heavy metal scan, or tailored impurity screens. Minimum order quantities align with package format and production campaign schedules; standard cases and drums in metric ton lots meet most industrial applications, with some flexibility for repeat batch off-takes or sample lots for qualifying new specifications.

Packaging Options

Grade selection dictates both container type and barrier requirements. Food-grade and pharma-intermediate GABA demands inert liners and tamper-evident sealing—with recycling and traceability features built in for customers in the US and EU. Industrial and feed-bulk formats use heavy-duty multi-layer bags or high-integrity drums for warehouse stacking and export containerization. Each format is tested for interaction and migration under relevant storage conditions and supply chain timeframes. Moisture control and light-exclusion rank as dominant design drivers, especially for regions with high-temperature transit.

Shipping & Payment Terms

Freight and delivery protocols depend on channel and incoterms. Direct domestic shipments typically ship ex-works, with customer-arranged pick-up. Major seafreight routes (FOB/CFR/CIF) leverage both bulk and containerized shipments. Payment structures reflect risk and contractual history—documentary collection, telegraphic transfer, and LC arrangements are all standard for new and existing customers. Pre-shipment sampling and third-party verification add to lead times for some destinations.

Pricing Structure & Influencing Factors

Raw Material Cost Composition

GABA's price structure reflects more than the current cost of input amino acids or fermentation media. Raw glutamic acid, enzymatic systems, and downstream reagents—often with volatile price nodes—drive batch costing. Labor rate shifts, energy inputs (especially for vacuum drying steps), and cost of compliance materials weigh heavily on margin structure. Sourcing biologically-derived fermentation agents instead of purely synthetic catalysts reflects both customer demand and tightening regional import controls.

Fluctuation Causes

Input cost shifts, especially for monosodium glutamate and energy, directly affect plant gate price. Policy shifts or trade actions, such as Chinese export quotas or changes in EU safety certification, may suddenly change raw material sourcing or process route selection. Tightening rules on microbial source certification can strand input supply lines, amplifying cost swings. End-user segment demand (nutraceutical versus animal feed) further splits market, with nutraceutical growth pulling more raw materials into higher-value streams.

Grade, Purity & Packaging Certification as Price Drivers

Price ranges separate strongly along final grade lines. Food and pharma-intermediate GABA require deeper impurity screens and tighter heavy metal limits, involving higher input material premiums and longer batch holding periods. Packaging certification further narrows downstream logistics choices and commands a price premium, especially for EU clients requiring full lot traceability. Technical and feed grades use more streamlined manufacturing and QA/QC protocols, passing on lower costs per unit of active content. Pricing by grade reflects not only concentration but specific impurity and bio-origin criteria in the product specification.

Global Market Analysis & Price Trends

Global Supply & Demand Overview

Asia Pacific remains the principal producing region, tracking both raw input sourcing advantages and concentration of process development expertise. Demand continues to diversify, with Asia and North America showing robust interest in nutraceutical and specialty feed applications. Regulatory approval velocity controls market entry timeline in Japan, the EU, and the US, often leading to sequential—not simultaneous—price response across these regions when process innovation occurs. India follows with expanding nutraceutical and API demand, yet infrastructure and cold chain gaps continue to influence available pricing tiers and supply security.

Key Economies Analysis (US/EU/JP/IN/CN)

North America exhibits steady import reliance with minimal local production. US buyers prioritize product origin documentation, and price reacts faster to global shipping conditions than to local feedstock changes. The EU market puts a premium on REACH and EFSA compliance for higher-grade GABA, often introducing lagged price increases after regulatory update cycles. Japan restricts certain microbial input agents more strongly than other economies; thus, production partners with lengthy approval cycles drive up local price floors. India—despite a growing local feed and supplement market—still contends with logistics instability, creating regional flux in landed pricing. China's robust fermentation infrastructure stabilizes both supply and internal pricing, while also acting as a swing producer for export surges.

2026 Price Trend Forecast

Three main factors will steer the price by 2026: tighter process controls in export hubs, increased regulatory demand for traceability and impurity profiling, and a fragmented supply landscape as major economies shift toward local certification schemes. Incremental capacity buildout, notably in China and India, may temporarily ease price pressure unless matched by raw material cost inflation. Nutrition and wellness sectors will likely draw more technical-grade capacity into higher-margin, higher-purity output streams, increasing grade separation in pricing. Persistent volatility in biological fermentation media and specialty catalysts may add further spikes to commodity and intermediate grades throughout the medium term.

Data Sources & Methodology

Analysis draws on multi-year plant and logistics data, regulatory change tracking, multi-national procurement trend analysis, and direct input from global supply chain partners. Pricing and volume assessments rely on a combination of proprietary client order history, published customs databases, regional commodity analyst forecasts, and output from ongoing EU, US, and Asian registration and compliance proceedings.

Industry News & Regulatory Updates

Recent Market Developments

Biotechnological advances in enzyme use and process optimization have enabled higher batch yield and improved impurity profiles, especially for pharma-intermediate GABA. Several producers have launched or announced expansion lines in East Asia and India specifically targeting the food and supplement channel. M&A activity among API and specialty chemical producers continues to realign global distribution of supply nodes.

Regulatory Compliance Updates

Rising demand for allergen-free processing and non-animal-origin certification has prompted tighter change control and more robust documentation procedures at the plant level. Global authorities are phasing in updated heavy metal and microbe tolerance thresholds for nutraceutical and food application GABA, especially in the EU and Japan. US FDA updates targeting labeling accuracy and traceability have spurred new batch tracking systems for US-bound supply.

Supplier Response & Mitigation

To address ongoing input and compliance volatility, process redesigns optimize both raw material utilization and energy footprint. Sourcing teams emphasize multi-source supplier qualification, emphasizing both regional and global redundancy for feedstock. Plant QA/QC functions invest in real-time tracking and release documentation. Customer technical support now covers change notification, co-validation, and consultation for specification adjustment in response to evolving regulatory guidance.

Gamma-Aminobutyric Acid (GABA) Application Fields & Grade Selection Guide

Application Fields & Grade Matching Guide

Industry Applications

GABA serves distinct functions depending on its target sector. Food and beverage formulators use certain GABA grades in dietary supplements, functional drinks, and nutraceuticals. Pharmaceutical manufacturers consider GABA for oral formulations or as part of excipient blends. Animal nutrition companies evaluate specific purity levels for premix and feed application. Technical and specialty grades sometimes support synthesis or chemical intermediate needs in fine chemicals, fermentation aids, or laboratory research.

Grade-to-Application Mapping

Application Typical Grade Expected Feature
Food & Beverage Food/USP/Pharma grade Low residual solvents, allergen control, batch traceability
Pharmaceutical API/Pharma grade Enhanced microbiological control, stringent impurity profile, regulatory documentation
Animal Feed Feed grade Standardized purity appropriate for species safety, absence of heavy metals above regulatory limits
Technical/Industrial Technical grade Process-specific impurity thresholds, broader acceptance for non-consumable applications

Key Parameters by Application

  • Purity: Product grade and targeted application drive the required assay specification. Pharmaceutical and food markets often call for higher minimum purity and lower by-products. Feed and technical uses prioritize functional consistency and absence of specific regulated contaminants over ultra-high purity.
  • Impurities: Residual solvent, heavy metals, and organic impurities originate from raw materials, process chemistry, or downstream handling. Removal strategy and final acceptance levels respond to the grade’s end-use.
  • Microbial Control: Applications sensitive to contamination, such as ingestible products, warrant validated disinfection procedures and release tests for pathogenic organisms. Feed and technical customers may set alternative acceptance criteria.
  • Sensory or Physical Properties: Depending on the end use, appearance, solubility, particle size, and bulk density impact handling and processing performance. These characteristics may show grade-dependent variance due to process route or finishing method.

How to Select the Right Grade

Step 1: Define Application

Determine if GABA will serve a human nutrition, pharmaceutical, animal nutrition, or industrial synthesis process. Downstream processing, regulatory exposure, and safety profile will dictate preferred grade and specification.

Step 2: Identify Regulatory Requirements

Document the compliance environment relevant to your region and application. Food and pharmaceutical supply chains often fall under local or international regulatory standards, including those set by FDA, EMA, GB, or similar agencies. Feed grade typically addresses agricultural authority standards. Technical use follows local chemical management regulation.

Step 3: Evaluate Purity Needs

Align the required GABA purity and impurity profile with functional and legal requirements. Higher-grade material serves direct human or animal consumption. Applications without intake risk or with further downstream purification may accept technical grades. Manufacturer analytical certificates align with internal test results and customer-specific requests.

Step 4: Consider Volume & Budget

Quantify usage expectations and project cost targets. High-purity and regulatory-verified grades command higher pricing due to increased raw material, analytical, and process controls. Greater batch volume may support cost efficiencies, provided specification range matches application needs.

Step 5: Request Sample for Validation

Engage technical support to obtain representative samples for pilot-scale validation and analysis. Quality control teams provide batch documentation and assist with physical and functional compatibility evaluation. Feedback from downstream processing or formulation trials determines final approval prior to full-scale commitment.

Trust & Compliance: Quality Certifications & Procurement Support for Gamma-Aminobutyric Acid (GABA)

Quality Compliance & Certifications

Quality Management Certifications

Our GABA manufacturing lines operate under regular audits and certification cycles. This ensures batch traceability, deviation management, and change control follow documented protocols at each processing stage. Adherence to internationally recognized quality systems, such as ISO-compliant frameworks, guides the workflow—from raw material acceptance through in-process checks to final product release. For commercial customers with custom audit demands, site-specific compliance can match sector expectations, including food, pharma, or feed sectors upon agreement and based on the required grade.

Product-Specific Certifications

Certificate issuance always correlates with batch record review and laboratory test confirmation. Kosher, Halal, and other compliance declarations remain batch-specific and tied to verified process controls at critical steps like crystallization, filtration, and packaging. Full underpinning is available for allergen management, GMO-status declarations, and BSE/TSE statements, depending on raw material origin and processing aids. Specifications for feed, food, or pharma grades pivot on the intended downstream use and contractual agreements.

Documentation & Reports

Each lot of GABA is released only after QA validates identity, purity, and impurity profiles against reference standards for the specified grade. Certificates of Analysis (CoA) provide actual test data, with attributes determined by customer purchase order and local regulatory requirements. Material Safety Data Sheets (SDS) support occupational health routines and hazard communication requirements across jurisdictions. Custom documentation, including origin trace, impurity summary, or stability profiles, is prepared when required by customer protocol or regulatory registration.

Purchase Cooperation Instructions

Stable Production Capacity and Flexible Business Cooperation Plan

Production lines operate with multi-batch scheduling, giving forward visibility for committed orders and surge supply when demand increases. Critical raw materials undergo dual-sourcing to protect continuity, with safety stock policies implemented for high-turnover grades. Customers requiring large or regular volumes can secure allocation through supply contracts, buffer stock, or collaborative forecasting arrangements.

Core Production Capacity and Stable Supply Capability

The core process route for GABA synthesis is chosen based on sustainability of precursor raw materials, regulatory acceptance of intermediates, and downstream impurity control. Batch size and frequency are balanced between short lead time deliveries and scale economies, with in-process analytics guiding release. Risk mitigation measures, such as backup utility systems and preventative maintenance planning, help minimize unscheduled downtime. Contracted customers often benefit from prioritized scheduling and reserved capacity as part of long-term agreements.

Sample Application Process

Sample requests undergo technical review to match customer intended use with available GABA grade. Application support addresses both technical compatibility and documentation needs, such as CoA, analytical methods, or regulatory dossiers. Response timelines are coordinated with production and analytical testing schedules, with shipment conditions and packaging options considered based on the sensitivity or storage needs of the sample grade.

Detailed Explanation of Flexible Cooperation Mode

Customers engaging with variable demand or mixed end-use requirements can access tailored delivery models, including spot purchase and blanket orders with scheduled call-offs. Flexible minimum order quantities depend on packaging configuration and grade availability. For customers seeking joint product development or specification adjustment, technical and sourcing teams collaborate to define quality parameters, adjust impurity controls, or align with customer registration projects. Payment terms, transport options, and labelling compliance are finalized during contracting, with contract management team oversight to ensure responsiveness to operational or regulatory changes.

Market Forecast & Technical Support System – Gamma-Aminobutyric Acid (GABA)

Research & Development Trends

Current R&D Hotspots

Contemporary industrial research into Gamma-Aminobutyric Acid focuses on improving downstream bioconversion yields and developing multi-step production using select strains or fermentation processes. A high level of interest surrounds the adaptation of feedstock strategies, particularly matching raw material profile to the purity requirements of specific end-use sectors such as dietary supplement, pharmaceutical, and food ingredient applications. In plant-extraction and fermentation-derived GABA, the focus is on biomass selection, precursor optimization, and reducing process-generated byproducts that can complicate downstream purification.

Emerging Applications

The main drivers for new application research include the rising demand for neuroactive functional ingredients in food and beverages, formulation of advanced dietary supplements, and uptake by personal care researchers targeting neurological pathways in skin health. In the technical field, R&D has started exploring GABA as a building block for biodegradable polymer intermediates and as a substrate in specialty chemical synthesis.

Technical Challenges & Breakthroughs

Producers encounter persistent technical constraints around decontamination of process-induced isomers, trace amine management, and protein fraction removal. Specific grades destined for injection or high-purity pharmaceutical use show variable impurity profiles, requiring frequent process re-tuning and advanced chromatographic steps. Recent breakthroughs in enzyme engineering and biocatalysis have opened routes that selectively boost gamma-aminobutyric acid production and decrease byproduct formation, though large-scale process robustness still calls for proven control strategies.

Future Outlook

Market Forecast (3-5 Years)

Market intelligence points to a steady rise in demand across nutraceutical and functional food markets, intensified by broader consumer awareness of stress modulation and sleep health benefits. Commercial buyers have signaled increasing inquiries for tight-spec bespoken grades, prompting manufacturers to invest in flexible production capability and rapid quality control adaptation. Volume growth projections remain grade-dependent, with the food/pharma interface accounting for the most dynamic product requirements.

Technological Evolution

Process technology adaptation centers on yield efficiency, impurity management, and continuous operation integration. Suppliers have directed R&D capital into more closed-loop processing, using advanced membrane separations and in-line purity monitoring systems to address batch variability. For some high-grade variants, process automation and digital quality analytics have enabled heightened batch-to-batch reproducibility, directly impacting downstream formulation reliability for customers.

Sustainability & Green Chemistry

Sourcing strategies are trending towards agricultural and fermentation-based inputs that originate from low-impact biomass or agricultural byproducts. Several commercial plants have scaled back non-renewable solvent usage, and some have introduced water-based extraction with anaerobic bioprocessing to reduce waste outputs. Major buyers in the supplement and food sectors are engaged in supplier dialogues emphasizing full-chain traceability, resource recovery, and minimized environmental burden, making LCA (Life Cycle Assessment) data a new negotiation point.

Technical Support & After-Sales Service

Technical Consultation

Direct engagement with customer R&D teams covers detailed discussion of feedstock traceability, impurity profile fit, and compatibility with specific formulation processes. Manufacturer technical staff maintain process logs and release analytics, providing these under confidentiality to buyers developing novel food, pharmaceutical, or specialty chemical products. Consultations often extend into raw material pre-tests and pilot runs, depending on client needs.

Application Optimization Support

For clients experiencing process upsets or batch inconsistencies, technical service engineers conduct on-site troubleshooting, root cause analysis, and process parameter adjustment recommendations. Known process-sensitive properties—such as solubility, dispersibility, and interaction with other actives in complex matrices—are usually mapped in detail for each order. Customization of particle size and purification degree is coordinated in close collaboration with the client's technical staff, to secure required downstream performance.

After-Sales Commitment

Ongoing commitments include batch record transparency, supply chain audit support, and assistance with regulatory documentation for end-use compliance. In case of deviation or unexpected result in final application, rapid investigations are initiated with traceable lot histories and representative retains. Replacement protocols and corrective action timelines are tailored to regional compliance needs and contractual requirements between manufacturer and customer.

Gamma-Aminobutyric Acid (GABA) for Industrial Buyers: Direct from the Manufacturing Source

Controlled Synthesis, Reliable Output

Our facility manages each step of Gamma-Aminobutyric Acid (GABA) production with precision, operating dedicated synthesis lines under regulated environments. We focus on batch and continuous production to align with large-scale industrial demand. Direct oversight at every stage ensures final product composition remains consistent, and each shipment matches agreed specifications—down to particle size, moisture level, and purity.

Serving Key Sectors with Solid Supply Chains

GABA supports functional food manufacturing, animal nutrition, pharmaceutical intermediates, and specialty chemical applications. Food and beverage formulators use our material for functional enhancements in fortification lines. Feed producers benefit from reliable flow and stability. Processed nutrient blends, dietary supplements, and custom compounders integrate GABA into established operations, relying on lot-tested batches for regulatory and product development cycles.

Why Product Consistency Drives Process Outcomes

Variations in raw materials can disrupt workflow, interrupt quality assurance programs, and slow downstream blending and filling lines. Our manufacturing standards operate by documented procedures, with retention samples and traceable records on each lot. In-line spectral and chromatographic checks, plus closed-loop control, hold batch properties within demanded ranges. Buyers report reduced hold-back rates and minimal lot-to-lot calibration.

Packaging and Delivery on Industrial Timelines

Our packaging operation moves bulk GABA in multi-ply bags, fiber drums with liners, or custom intermediate bulk containers. Automated filling lines allow for adaptation to client inventory systems, whether integrating with silos, automated bag handling, or direct processing. Consignment scale, stacking orientation, and humidity barriers get set for each order. Logistics run from our warehouse network, supporting order volumes from single lot to full container load, with flexible lead times and prioritized allocation for contracted customers.

Support for Technical and Procurement Teams

Product developers and technical managers often bring detailed processing or formulation concerns to the sourcing table. Our technical support group collaborates with plant engineers and R&D leaders on solubility limits, binder compatibilities, or shelf-life performance in specific matrices. Troubleshooting and process qualification run in close exchange with our lab teams; documentation includes full COA, method references, and traceability records to facilitate audits and compliance reviews.

Business Value to Manufacturers and Distributors

Direct control over GABA production—right to the warehouse door—means reliable schedules, credible documentation, and support that keeps processing lines moving. Distributors carrying our output maintain lower reconciliation rates and tighter cycle inventory, as specification consistency reduces rework and disputes. Procurement teams gain leverage in planning, as supply continuity links directly to our operating schedules and capacity forecasts. Full access to technical, regulatory, and supply chain input from a single manufacturing partner—without intermediaries—promotes visibility and mutual accountability at every stage.

Main Application Areas Buyer Benefits of Direct Factory Sourcing
Food and Beverage Fortification Consistent ingredient profile for secure product registration and labeling
Animal Feed and Nutrition Stable flow properties improve process uptime, reduce lot segregation
Pharma Intermediate Synthesis Full batch traceability for regulatory inspection and compliance
Specialty Chemical Compounding Custom packaging integrates with bulk handling systems

Continuous Improvement, Ongoing Dialogue

Chemical manufacturing shapes the pace and confidence of many industrial operations. By coordinating production output, technical knowledge sharing, and traceable supply, we make it easier for buyers to plan, execute, and supply their markets without interruption. Direct engagement with every stakeholder—technical, quality, and supply—accelerates issue resolution and creates value for every participant in the chain.

Industrial FAQ

What is the purity level and molecular structure specification for the Gamma-Aminobutyric Acid (GABA) product?

Direct Perspective from Our Manufacturing Line

From our position at the source, we pay close attention to both the purity and the molecular structure of Gamma-Aminobutyric Acid (GABA) at every step. Over the years, we’ve optimized our processes to filter out unwanted byproducts and impurities, delivering GABA that consistently meets or exceeds 99% purity for food and pharmaceutical use. This consistency stems from managing every variable on our production floor and relying on regular batch analysis in our own labs. We use validated liquid chromatography and mass spectrometry to confirm the absence of significant contaminants and confirm the main analyte. Success in these tests forms the bedrock for GABA used in sensitive applications, from supplements to advanced research reagents.

Molecular Structure – Precision at Every Batch

The molecular formula for our GABA product is C4H9NO2, with a molar mass of 103.12 g/mol. We ensure our material is strictly the zwitterionic form, which is chemically stable and functionally suitable for neurological, nutritional, and technical formulations. Our technical team pays close attention to stereochemistry, producing racemically pure GABA where only the natural form (4-aminobutyric acid) is present. Reliable nuclear magnetic resonance (NMR) and infrared spectroscopy verify correct structure and exclude isomeric impurities every run.

Why High Purity and Structural Confirmation Matter

GABA functions as a major inhibitory neurotransmitter, so trace impurities matter. Residual solvents, heavy metals, or amino acid analogs can disrupt research accuracy or raise regulatory flags. Over time, we’ve seen that herbal extracts or fermentation sources can introduce variability, which is why our chemical synthesis and purification trains—solid phase or enzymatic—have strict checkpoints. Consistency in purity directly impacts our customers’ output: whether that’s reliable supplements for consumer health, or reproducible results in scientific labs.

Continuous Improvement and Compliance

We routinely review our analytical routines, not just for internal assurance but in response to customer audits and shifting standards. ISO-focused internal protocols, validated against reference materials, help keep us ready for new regulatory demands. Each outgoing batch of GABA carries a certificate stating actual purity (usually exceeding 99%) and includes data on metal content, residual solvents, and microbiological index. Stability studies track possible degradation, and our team maintains retention samples so we can trace any customer concern back to its production root.

Working with You: Information and Ongoing Support

Our technical documentation details our synthesis, filtration, and verification stages. For process changes or stricter end-use applications, we provide full disclosure of analytical methods and sample chromatograms. We are manufacturers, not middlemen. Every lot originates in our own facilities, so we respond to inquiries with direct lab data and production control reports. This approach keeps our feedback relevant, fast, and based on firsthand technical experience. Our team believes high-purity GABA can only come from rigorous production discipline and openness throughout the manufacturing chain.

What are the minimum order quantity and lead times for bulk procurement of GABA?

Understanding Bulk Orders from the Factory Floor

As a direct manufacturer of gamma-aminobutyric acid (GABA), we face many inquiries about both minimum order quantity (MOQ) and lead time for bulk fulfillment. In the chemical manufacturing business, these two topics shape both our production planning and how our customers approach long-term projects.

Practical MOQ Realities

For our food-grade and feed-grade GABA, the MOQ usually starts at 500 kilograms. The reason is simple: our factory setup, batching, and QC procedures are engineered for volume output. Processing small lots disrupts the production schedule and introduces potential risk in quality consistency. Large tank reactors, blending units, and automated packaging lines cannot operate with micro-lots. Any genuine bulk order integrates seamlessly as our standard packaging is 25 kg per fiber drum or multi-layer kraft bag, loaded directly from our line.

International logistics and export documentation also push us toward larger order sizes. Handling regulatory filing, custom inspection, and shipping container optimization works more efficiently at higher volumes. Smaller orders do not allow the costs to be spread out, impacting unit economics for us and for our customers. Our partners in nutraceuticals, animal nutrition, and specialty fermentation leverage these economies of scale for their business margins as well.

Transparency in Lead Times

Lead times for GABA bulk orders depend on two main factors: current production schedule and pre-packed stock levels. Our factory operates batch reactors on a planned calendar. In peak demand periods, lines are fully committed weeks in advance. For regular contract partners and customers with stable repeat orders, we integrate requirements into the monthly schedule to achieve a reliable 14 to 21-day lead time.

For new bulk orders or projects needing specific documentation, custom formulation, or third-party pre-shipment inspection, we recommend at least a 3 to 4-week window. This allows time for in-house QC, full material traceability checks, and regulatory paperwork which cannot be rushed without compromising compliance. Raw material delays or unplanned upticks in large-scale orders can extend lead times, and we proactively communicate scheduling conflicts to clients before confirmation.

Mitigating Procurement Risks

Working with raw material supply chains gets more challenging each year, especially with international disruptions and new compliance rules. To keep production on track, we maintain robust strategic sourcing and safety stock for critical inputs. GABA synthesis at scale also depends on utility stability (steam, water, power) and equipment uptime; our maintenance and process teams meet every week to review ongoing performance to prevent bottlenecks.

To help customers manage their operational cycles, our logistics and planning team can offer annual call-off contracts and flexible split shipments within larger frameworks. These agreements lock in both production slot and price, reducing risk for all sides. Ordering early and sharing forecasts helps us keep inventory flowing and output stable. This approach protects customers from market fluctuations and seasonality—two issues that have tripped up many buyers sourcing from spot markets or piecemeal intermediaries.

Factory Perspective on Reliable Supply

From our vantage point at the production site, open communication and advance planning remain the most important tools for reliable procurement of GABA. Bulk buyers looking for steady quality and clear delivery dates benefit from working directly with our technical and commercial teams. We rely on this direct relationship to align product specs, delivery windows, and documentation needs before a single drum gets filled. This results in smoother shipments, less downtime, and fewer surprises on either end.

Does the GABA product meet current import/export regulatory standards, and are all required safety data sheets (SDS) and certificates compliant with destination country regulations?

Regulatory Compliance Starts on the Factory Floor

Every drum of GABA shipping out of our facility has already traveled a path defined by regulation. Regulations set by authorities in destination countries—whether the US FDA, European REACH, Japan’s Pharmaceutical and Medical Device Act, or China’s GB standards—shape every protocol we build into our process. Our export team spends considerable resources decoding new or updated requirements because a shipment faced with customs delays or rejection represents much more than an inconvenience; it can disrupt supply chains on both ends.

Safety Data Sheets and Documentation Integrity

We draft our Safety Data Sheets using globally harmonized standards, ensuring each section—chemical properties, hazards, first-aid measures, exposure controls, disposal considerations—meets up-to-date requirements. Our regulatory affairs and chemical safety team reviews every new edition. This keeps our SDS documentation aligned with local language requirements and hazard communication formats, from OSHA’s HCS in the US to EU CLP regulations.

Our certificates—including Certificate of Analysis (COA), TSE/BSE free statements, and non-GMO declarations—track batch-by-batch traceability from raw synthesis through final QC release. These certificates are not just administrative. They act as functional gates to customs clearance, with relevant test methods, expiry dates, and batch numbers clearly presented to satisfy authorities in markets ranging from nutraceutical to food and pharmaceutical grade applications.

Responding to Changing Import/Export Rules

No industry, especially specialty biochemical manufacturing, stands still. For instance, Europe’s latest changes on contaminant thresholds for food additives have driven us to tighten QC methodologies, such as advanced chromatography and trace impurity screening, then document these changes in amended SDS and COA formats. In South Korea, updated registration for functional health ingredients led us to supply further toxicological and allergenicity data as part of the paperwork accompanying each GABA shipment.

We recognize that shifts in trade agreements or tighter port inspections in destination countries create real-world impacts. To avoid holdups, our export compliance team maintains an ongoing dialogue with regulatory agencies and certified labs, verifying that each document matches up-to-date regulatory requests rather than relying on past versions.

Quality Management Systems Drive Reliability

We operate under ISO-certified quality and environmental management systems. Incoming raw materials, in-process intermediates, and final products are linked to their documentation by unique identifiers in our ERP. Every GABA batch ships only with a complete, compliant document package, so downstream customers can seamlessly pass audits without last-minute data emergencies.

Transparent Support for Customized Regulations

Unpredictable documentation requests reach us regularly—requests for Halal or Kosher certification in some regions; proof of origin or CMR-free statements in others. Our technical team works closely with each buyer, pre-clearing sample paperwork with customs brokers or regulatory authorities if needed. We store validated document templates that address destination markets’ non-standard requirements, improving clearance speed.

Continuous Monitoring and Improvement

Regulatory standards will keep evolving. We invest in real-time monitoring of global regulatory databases and direct communication with officials to anticipate new demands before they surprise our customers. This means the SDS and certificates for our GABA are built to clear customs today and with each future update, making them reliable business tools instead of potential liabilities.

Technical Support & Inquiry

For product inquiries, sample requests, quotations or after-sales support, please feel free to contact me directly via sales7@bouling-chem.com, +8615371019725 or WhatsApp: +8615371019725